Dieses Maus Monoklonal-Antikörper erkennt spezifisch beta Amyloid in WB, EIA und ELISA (Detection). Er zeigt eine Reaktivität gegenüber Human, Maus, Ratte und Primate.
This antibody specifically recognizes the C-terminal sequence of beta amyloid peptide 42 and full length beta amyloid peptide 42. The antibody does not cross react with beta amyloid peptide 40 in dot blotting and ELISA. Cross-reactivity to beta amyloid peptide 43 is less than 1 % in ELISA.
Kreuzreaktivität (Details)
Species reactivity (tested):Human, Primates, Mouse, Rat.
Aufreinigung
Protein G affinity purified
Immunogen
KLH conjugated to a short peptide corresponding to the C-terminal sequence of beta amyloid peptide 42
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Rekonstitution
Restore with Double distillated water is recommended and to adjust the final concentration to 1.0 mg/mL.
Buffer
0.01 M PBS pH 7.2
Handhabung
Avoid repeated freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C.
Target
beta Amyloid (Abeta)
(Amyloid beta (Abeta))
Andere Bezeichnung
Amyloid beta
Hintergrund
Amyloid beta peptide 42 (Aβ42) is best known for its role in the formation of senile plaques in the brain of patients with Alzheimer's disease. Aβ42 and Aβ40 are the two major amyloid peptides that are produced after cleavage of amyloid precursor protein by secretases. Aβ42 (42 amino acids) is very fibrillogenic. The beta pleated structure of Aβ42 constituents the initial and key component of the insoluble amyloid fibril in senile plaque. It is widely accepted that Aβ42 contributes to the pathogenesis of Alzheimer's disease. One proposition is that the deposition of amyloid fibril onto the brain tissue results in Alzheimer's disease. Another is that the neurotoxicity of Aβ42 oligomer is the cause of the disease.